S100A10 and exocrine pancreatic carcinoma: Additionally, in Pei’s datasets, S100A10/A11/A14/A16/P were found higher expressed in pancreatic carcinoma (fold change = 3.54, 4.95, 6.46, 4.40, 77.93) in comparison with normal samples.